Hormone Replacement Therapy
When to start, how to deliver it, and which hormones actually protect you
Conviction: HighTonight, ask yourself: is someone you care about approaching or past menopause without having discussed HRT with their doctor? If yes, send them this — the window for maximum benefit closes within 10 years of menopause.
Think of your blood vessels like a garden hose. When it's new, it's flexible — estrogen keeps it that way. After menopause, without estrogen, the hose slowly hardens and cracks. If you start watering (HRT) while the hose is still flexible — within 10 years of menopause — you keep it supple. Wait until it's already cracked and rigid, and the water pressure can actually make the cracks worse. That's exactly what happened in the 2002 study that scared everyone: they gave hormones to women whose "hoses" had already hardened.
When to start, how to deliver it, and which hormones actually protect you
Conviction: HighAsk yourself: is someone you care about approaching or past menopause without having discussed HRT with their doctor?
If yes, send them this. The window for maximum benefit closes within 10 years of menopause, and most doctors still aren't prescribing based on the updated evidence.
Tonight. One conversation could change a health trajectory.
The Verdict
HRT protects hearts and saves lives — but only if started early, worn as a patch, and paired with natural progesterone.
Think of your blood vessels like a garden hose. When it's new, it's flexible — estrogen keeps it that way. After menopause, without estrogen, the hose slowly hardens and cracks. If you start watering (HRT) while the hose is still flexible — within 10 years of menopause — you keep it supple. Wait until it's already cracked and rigid, and the water pressure can actually make the cracks worse. That's exactly what happened in the 2002 study that scared everyone: they gave hormones to women whose "hoses" had already hardened.
Want the full evidence? Keep scrolling
Camp one believes HRT universally causes breast cancer, heart attacks, and strokes. This fear was cemented by the 2002 Women's Health Initiative trial, which slashed prescriptions from 25-30% of postmenopausal women to just 3-4%. An entire generation of women was told hormones would kill them.
Camp two — the anti-aging and biohacking community — believes custom-compounded "bioidentical" hormones are a risk-free fountain of youth, inherently safer than anything a regular pharmacy stocks.
Both camps are wrong. And the stakes of being wrong in either direction are life-altering.
The DOPS trial (Schierbeck et al., 2012) followed 1,006 recently menopausal women for 10 years in a randomised trial. HRT reduced the combined risk of death, heart failure, and heart attack by 52%.
That's not a typo. Across 30 randomised trials, the consistent finding is a 39% reduction in death from all causes when HRT is started in women under 60.
The WHI trial enrolled women averaging 63 years old — about 12 years past menopause. It found increased heart risk. The ELITE trial (Hodis et al., 2016) confirmed it directly: estrogen slowed artery thickening by 44% in women less than 6 years past menopause, but had zero effect in women 10+ years out.
Here's what's really happening: your blood vessels must still be flexible for estrogen to protect them. Once plaque has built up, adding estrogen can destabilise it. The hormone isn't the problem — the timing is.
When you swallow estrogen as a pill, it hits the liver first and drives up clotting factors. A 2023 systematic review (Goldstajn et al.) found that oral HRT doubles the risk of blood clots compared to patches or gels.
Patches and gels bypass the liver entirely — they deliver estrogen straight into the bloodstream through the skin. The result: risk-neutral for both clots and stroke.
The E3N study followed 80,377 women for 8 years. Estrogen plus natural progesterone: no increase in breast cancer whatsoever. Estrogen plus synthetic versions: a 69% increase.
The reason is receptor cross-talk. Synthetic versions don't just hit the progesterone receptor — they also trigger androgen and stress hormone receptors, causing abnormal breast cell division that the natural molecule doesn't.
"Bioidentical" describes the molecule — it means the hormone is chemically identical to what your body makes. It does not describe the pharmacy that made it.
Custom-compounded hormones lack regulatory oversight, have batch-to-batch variability in dosing, and frequently use progesterone creams that absorb too poorly to actually protect the uterine lining — which raises the risk of uterine cancer. FDA-approved bioidentical hormones (patches, capsules) are rigorously tested and widely available.
Side A: WHI (Manson et al., 2002/2013) — N=16,608
Combined HRT increases heart disease risk and overall mortality. Used oral horse-derived estrogens + synthetic progestins in women averaging 63 years old — about 12 years past menopause.
Side B: DOPS (2012) & ELITE (2016) — N=1,006 & N=643
HRT reduces cardiovascular events by 52% and slows arterial aging when started early. Used estrogen in recently menopausal women with appropriate delivery and hormone types.
Verdict: Side B has the stronger evidence. The WHI's apparent harm was driven by three simultaneous problems: late timing (arteries already had plaque), oral delivery (liver-first processing spiked clotting), and synthetic hormones (off-target receptor effects). Control for all three — as DOPS and ELITE did — and HRT is powerfully protective.
"Too late" has caveats. The hard cutoff — over 60 or over 10 years past menopause — applies specifically to heart protection. HRT may still help with bone density and symptom relief beyond this window. The risk-benefit calculation shifts, but it doesn't become zero. It's not "never start after 60" — it's "don't start after 60 expecting your heart to benefit."
Oral estrogen isn't always wrong. Pills raise good cholesterol and lower bad cholesterol more effectively than patches. For a woman with low clot risk and poor cholesterol ratios, oral delivery might have a niche. But patches remain the default recommendation for the vast majority of women because the clot risk reduction outweighs the cholesterol advantage.
Duration is still unresolved. Most guidelines suggest reassessing HRT every 1-2 years. The DOPS trial showed benefits at 10 years with no cancer increase, but long-term data on natural progesterone beyond 8 years is limited. With natural progesterone, the safety window appears longer than with synthetic versions — but "appears longer" isn't the same as "proven safe indefinitely."
Want help optimising your nutrition and training around hormonal health? Work with SLH Fit
Produced by SLH Fit Coaching · Truth Engine · Not medical advice.
How strong is the evidence for the claims in this review? Higher = more confidence the claims are supported. This does not measure how large the effect is or how important it is compared with other levers.
Conviction-scored health research in your inbox. What works, what doesn't, and what the studies actually measured.
Subscribe freeConviction-scored verdicts on supplements, nutrition, training, physio, and recovery.